ANVS
Annovis Bio Inc
NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY
$1.13
+10.78% today
Updated 2026-10-30
Market cap
$40.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.69
Dividend yield
—
52W range
$1 – $6
Volume
1.0M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.8
Quality
C3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-12.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →246 stocks currently score above 75
Price targets
Analyst target
$10.50
+829.20%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -12.14 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-21.91M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-25.15M | $-56.20M | $-24.59M | $-28.85M | $-14.82M |
| EPS | — | — | — | — | $-1.69 |
| Free cash flow | $-17.31M | $-39.97M | $-21.89M | $-25.62M | $-21.91M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Annovis Bio Inc trades at $1.13. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -12.14, it sits in the distress.
Frequently asked questions
What is Annovis Bio Inc's stock price?
Annovis Bio Inc (ANVS) trades at $1.13.
Is Annovis Bio Inc overvalued?
Annovis Bio Inc carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Annovis Bio Inc (ANVS)?
The 12-month analyst consensus target is $10.50, about 829.2% above the current $1.13. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Annovis Bio Inc's Altman Z-Score is -12.14, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio—
ROE-220.60%
Beta1.23
50D MA$1.42
200D MA$2.05
Shares out0.04B
Float0.04B
Short ratio—
Avg volume1.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—